Prana Biotechnology Ltd. (Nasdaq:PRAN) has received a key papers that will allow it to have moreprotection for its Alzheimer’s candidate. FULL DETAILS are over at BioHealtInvestor.com. The press release hit at 10;15 and at 10:30 AM EST we have already seen 112,000 shares trade hands compared to an average volume of most 35,000 shares. Shares are today up 18% and almost at $2.00; the 52-week trading range is $1.00 to $4.28. For a comparison, there was volume of 263,000 on August 5 (EU papers date) and this one spiked big by over 50% to $1.70 on over 500,000 shares back on July 10 when the company announced data showing approximately 40% of PBT2 aerated patients substantially outperformed placebo patients. -JON OGG
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment